1. Cloning-free CRISPR
- Author
-
Arbab, Mandana, Srinivasan, Sharanya, Hashimoto, Tatsunori, Geijsen, Niels, Sherwood, Richard I, Onderzoek, CSCA TR1, Regenerative Medicine, Stem Cells & Cancer, Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science, Srinivasan, Sharanya, Hashimoto, Tatsunori Benjamin, Onderzoek, CSCA TR1, Regenerative Medicine, Stem Cells & Cancer, and Hubrecht Institute for Developmental Biology and Stem Cell Research
- Subjects
Resource ,Cells ,Transgene ,Biology ,Research Support ,Biochemistry ,N.I.H ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Plasmid ,Research Support, N.I.H., Extramural ,Genetics ,Journal Article ,CRISPR ,Animals ,Humans ,Cloning, Molecular ,Non-U.S. Gov't ,lcsh:QH301-705.5 ,Gene ,Gene knockout ,Cells, Cultured ,030304 developmental biology ,lcsh:R5-920 ,0303 health sciences ,Cultured ,Cas9 ,Research Support, Non-U.S. Gov't ,Extramural ,Molecular ,Gene targeting ,Cell Biology ,HEK293 Cells ,lcsh:Biology (General) ,Gene Targeting ,CRISPR-Cas Systems ,lcsh:Medicine (General) ,Homologous recombination ,030217 neurology & neurosurgery ,Cloning ,Developmental Biology - Abstract
We present self-cloning CRISPR/Cas9 (scCRISPR), a technology that allows for CRISPR/Cas9-mediated genomic mutation and site-specific knockin transgene creation within several hours by circumventing the need to clone a site-specific single-guide RNA (sgRNA) or knockin homology construct for each target locus. We introduce a self-cleaving palindromic sgRNA plasmid and a short double-stranded DNA sequence encoding the desired locus-specific sgRNA into target cells, allowing them to produce a locus-specific sgRNA plasmid through homologous recombination. scCRISPR enables efficient generation of gene knockouts (∼88% mutation rate) at approximately one-sixth the cost of plasmid-based sgRNA construction with only 2 hr of preparation for each targeted site. Additionally, we demonstrate efficient site-specific knockin of GFP transgenes without any plasmid cloning or genome-integrated selection cassette in mouse and human embryonic stem cells (2%–4% knockin rate) through PCR-based addition of short homology arms. scCRISPR substantially lowers the bar on mouse and human transgenesis., National Institutes of Health (U.S.) (5UL1DE019581), National Institutes of Health (U.S.) (RL1DE019021), National Institutes of Health (U.S.) (1K01DK101684-01), National Institutes of Health (U.S.) (1U01HG007037), National Institutes of Health (U.S.) (5P01NS055923), Harvard Stem Cell Institute (Sternlicht Director's Fund Award)
- Published
- 2015